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Adenovirus minor coat protein VI contains a membrane-disrupting peptide which is inactive 
when VI is bound to hexon trimers. Protein VI must be released during entry to ensure 
endosome escape. Hexon:VI stoichiometry has been uncertain, and only fragments of VI have 
been identified in the virion structure. Recent findings suggest an unexpected relationship 
between VI and the major core protein, VII. According to the high resolution structure of the 
mature virion, VI and VII may compete for the same binding site in hexon; and non-infectious 
human adenovirus type 5 particles assembled in the absence of VII (Ad5-VII-) are deficient in 
proteolytic maturation of protein VI and endosome escape. Here we show that Ad5-VII- particles 
are trapped in the endosome because they fail to increase VI exposure during entry. This failure 
was not due to increased particle stability, because capsid disruption happened at lower thermal 
or mechanical stress in Ad5-VII- compared to wildtype (Ad5-wt) particles. Cryo-EM difference 
maps indicated that VII can occupy the same binding pocket as VI in all hexon monomers, 
strongly arguing for binding competition. In the Ad5-VII- map, density corresponding to the 
immature amino-terminal region of VI indicates that in the absence of VII the lytic peptide is 
trapped inside the hexon cavity, and clarifies the hexon:VI stoichiometry conundrum. We 
propose a model where dynamic competition between proteins VI and VII for hexon binding 
facilitates the complete maturation of VI, and is responsible for releasing the lytic protein from 
the hexon cavity during entry and stepwise uncoating. 
 
Significance Statement 
To achieve their full infectious potential, virus particles transition from relatively inert to highly 
reactive agents upon encountering an appropriate host cell. Here we examine the basis for this 
transition in adenovirus, a human pathogen and widely used gene transfer vector. Adenovirus 
particles contain more than ten different proteins plus the viral genome. We focus on the 
interplay between two of these proteins: the major core protein VII, involved in genome 
condensation, and the internal minor coat protein VI, bearing lytic activity required to rupture 
endosomes during entry. Our data support a model where the ability of protein VII to compete 
with VI in hexon binding facilitates proper exposure of the lytic peptide, ensuring virion escape 





Adenoviruses are complex non-enveloped, double-stranded DNA (dsDNA) viruses. The virion of 
human adenovirus type 5 (HAdV-C5) consists of a 95 nm diameter icosahedral pseudoT = 25 
protein shell enclosing a non-icosahedral DNA-protein core. The capsid is composed of 240 
hexon trimers, 12 pentameric penton bases associated with a fiber sitting at each vertex, and 
four minor coat proteins: polypeptide IX (240 copies) on the outer capsid surface, and proteins 
IIIa (60 copies), VI (~320 or 360 copies, depending on two different stoichiometry 
determinations), and VIII (120 copies) on the inner one (1-4). Inside the capsid, the ~36 kbp 
linear dsDNA genome is tightly packed together with ~25 MDa of protein: ~500-800 copies of 
polypeptide VII, ~100-300 copies of polypeptide µ, and 150 copies of polypeptide V (3, 4). 
Because the three core proteins have a large proportion of positive charges, it is expected that 
their main role is to help screen the electrostatic repulsion of the confined, negatively charged 
genome (5). 
During maturation, the adenovirus protease (AVP) cleaves the precursor forms of minor coat 
proteins IIIa, VI, and VIII, as well as core proteins VII and µ, the terminal protein, and the 
packaging protein L1 52/55 kDa (6-8). AVP enters the viral particle bound to the DNA molecule 
(its first cofactor) and cleaves 11 residues from the C-terminus of the polypeptide VI precursor 
(pVI). The released peptide (pVIC) is AVP second cofactor, which the protease uses as a sled to 
scan along the dsDNA and reach the rest of its targets (9-11). These include, among others, a 
second cleavage site at the N-terminal region of pVI (releasing a 33 residue-long peptide, pVIN), 
and two N-terminal cleavage sites in the precursor of the major core protein, pVII, releasing 
peptides pVIIN1 (residues 1-13) and pVIIN2 (14-24) (6). 
Protein VI is located beneath the hexon shell (2, 12) and its membrane lytic activity is crucial for 
adenovirus cell entry (13-17). Immature adenovirus particles contain the precursors of all viral 
AVP substrates. They assemble and package correctly, but fail to expose the pVI lytic peptide 
(an amphipathic α-helix at the N-terminus of protein VI) during entry, become trapped in endo-
lysosomes and therefore are not infectious (18-21). This happens because immature particles 
are more stable than the mature virions (22-24), and do not respond to the cues from receptor 
movements and confinements when bound to the plasma membrane (16, 25-27). Maturation of 
the core proteins increases the internal pressure generated by electrostatic repulsion between 
the confined DNA strands (28). This pressurization seems to provide a mechanism to facilitate 
penton release upon receptor interaction, which in turn opens the way for exposure of the lytic 
peptide (22, 23).  
Two recent studies have shown unexpected connections between proteins VI and VII. In the 
first one (29), loxP sites were inserted in the human HAdV-C5 genome flanking the pVII gene 
(Ad5-VII-loxP). When Ad5-VII-loxP infects cells expressing the Cre-lox recombinase, pVII is not 
expressed because the VII locus is excised from the viral genome. The first surprising result 
was that the absence of the major core protein did not hinder particle formation and genome 
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encapsidation. Therefore, the DNA condensation activity of protein VII is not necessary for the 
adenovirus genome to fit inside the capsid. The second surprise in this study was that, in the 
particles lacking protein VII (Ad5-VII-), protein VI was present in an intermediate maturation 
form (iVI), having been cleaved only at its C-terminal site, but not at the N-terminus. 
Additionally, Ostapchuk and collaborators found that the Ad5-VII- particles were not infectious 
due to a defect in entry: these particles were unable to escape from the endosome, similarly to 
the fully immature particles produced by the thermosensitive mutant Ad2 ts1 (19, 30). 
Why full maturation of pVI is impaired in the absence of core protein VII, and why the particles 
lacking VII are trapped in the endosome, has remained unclear. The fact that pVI was 
processed at the C-terminus means that AVP was able to produce its cofactor (pVIC), become 
activated, and process the rest of its substrates, because neither full length L1 52/55 kDa nor 
pVIII were detected in Ad5-VII- particles (29). However, AVP could not cleave pVIN, which in 
vitro is the first site processed in pVI (10). The N-terminal cleavage of pVI occurs directly 
upstream of the region containing the amphipathic α-helix (residues 34-54) involved in 
endosome membrane disruption (13, 14). This cleavage may not be required for the lytic activity 
of the helix, because recombinant pVI is able to disrupt liposome membranes in vitro (13).  
The second study revealing unexpected relationships between proteins VI and VII is the most 
recent cryo-electron microscopy (cryo-EM) analysis of the HAdV-C5 capsid structure (2). 
Structural and biochemical analyses had previously shown that the pVIN peptide is located 
inside a central cavity of the hexon trimer that opens towards the viral core, but density for pVIN 
was weak and present only in a few hexons, indicating lack of icosahedral order, or partial 
occupancy (12, 31, 32). Partial occupancy is also implied by the hexon and pVI copy numbers 
in the virion: there are too many copies of pVI (~360) to have one per hexon trimer (240), but 
too few to have one per hexon monomer (720). In (2), an increase from 3.5 to 3.2 Å resolution 
provided new information on the molecules generating weak density inside hexons. First, at the 
mouth of the hexon cavity, residues 109 to 143 of pVI were modeled, disconnected from pVIN. 
Second, the pVIN tracing was reversed with respect to the previous structures (31, 32), in such a 
way that in the latest model (2) the pVIN cleavage site is not accessible at the rim of the hexon 
cavity, but hidden inside and oriented away from the core. This new disposition makes it more 
difficult to understand how AVP, sliding on the DNA, can reach its target sequence in pVIN (see 
SI Appendix, Fig. S1). Third, it was shown that one of the densities inside the hexon cavity did 
not correspond to pVIN, but to the second N-terminal peptide cleaved from core protein VII 
(pVIIN2). This observation was also unexpected, because as a core protein, no part of VII was 
thought to be icosahedrally ordered, and there were no previous indications that pVII interacted 
with hexon. The pVIIN2 peptide occupies a position equivalent to that of pVIN, lining the hexon 
cavity wall. Residues Ser31 in pVIN and Phe22 of pVIIN2 interact with the same binding pocket in 




In another report, we have analyzed how the absence of protein VII impinges on the mechanical 
properties and core organization of the HAdV-C5 particle (33). We showed that the entry defect 
of Ad5-VII- particles could not be attributed to either lack of internal pressure or excessive 
binding of the naked DNA to the capsid shell. Here, we analyze exposure of protein VI, capsid 
stability and capsid structure in Ad5-VII-, in search of the reasons why these particles are 
impaired in pVI maturation and endosomal escape. Our results show for the first time the 
organization of the pVI lytic peptide inside the hexon cavity before pVIN cleavage, and provide 
the basis for a model in which competition between the precursors pVI and pVII for hexon 





Exposure of membrane lytic protein VI is impaired in the absence of core protein VII 
For protein VI to mediate endosome disruption, the lytic peptide (amphipathic helix in residues 
34-54) needs to be released from the interior of the viral particle (13). Therefore, we 
investigated whether lack of protein VII had an effect on exposure of protein VI upon viral entry. 
To this end, we characterized the exposure of protein VI in human A549 cells infected with atto 
565-labelled viral particles upon cell entry. The amount of internalized particles was estimated 
by counting the dots positive for atto 565 but negative for monoclonal anti-hexon labeling in 
non-permeabilized cells. As expected (29), the Ad5-VII- virus did not present difficulties in cell 
internalization (see SI Appendix, Fig. S2). The signal for protein VI obtained after cell 
permeabilization in HAdV-C5 wildtype (Ad5-wt) internalized particles increased between 5 and 
10 times during the first 10 min of infection, indicating progressive exposure of VI from the 
incoming particles (Fig. 1). This was consistent with earlier reports demonstrating exposure and 
complete loss of VI from the virions upon endosomal rupture and virion release to the cytosol 
(16, 34). In simultaneous experiments with Ad5-wt and Ad5-VII- particles (Fig. 1), we observed 
that the Ad5-VII- virus tended to show higher amounts of protein VI signal at the 0 min time 
point than the Ad5-wt virus, suggesting the presence of damaged particles in the preparations, 
a possibility that was supported by negative staining electron microscopy (EM) imaging (see SI 
Appendix, Fig. S3). Unlike Ad5-wt, Ad5-VII- did not show an increase in protein VI exposure in 
the first 20 min of infection after warming of cold synchronized cells (Fig. 1b). Out of four 
experiments (three biological replicates for one Ad5-VII- preparation and one test comparing in 
parallel four different Ad5-VII- preparations), we observed changes in the signal for protein VI 
ranging between a 2-fold decrease and a 1.5-fold increase during the first 10 min of infection. 
That is, while there was a clear increase in particle-associated anti-VI signal in Ad5-wt particles 
at 10 min in comparison to 0 min post-infection, the changes observed for the Ad5-VII- virus are 
within the experimental noise range, taking into account cell-to-cell variability. These results 
indicate that Ad5-VII- particles fail to properly expose the partially processed polypeptide VI as 
they enter cells, in agreement with the reported failure of Ad5-VII- to penetrate the endosome 
membrane (29). 
 
Adenovirus particles lacking protein VII have reduced thermal and mechanical stability 
The Ad5-VII- entry defect is reminiscent of that observed for particles produced by the Ad2 ts1 
mutant, which contain immature pVI and become trapped in the endocytic route (19, 30, 35). 
Ad2 ts1 particles are highly stable: they can withstand harsher conditions than Ad5-wt, require 
more stress to release pentons, and therefore do not release protein VI upon entry (16, 18, 19, 
22-24). Likewise, mutation G33A in pVI produces particles with partial processing of this protein, 
higher thermostability, lower membrane lytic activity, reduced infectivity, and more stable 
pentons (36, 37). To evaluate whether increased stability could be responsible for the lack of 
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protein VI release from Ad5-VII- particles, we carried out thermal and mechanical disruption 
assays. 
We used extrinsic fluorescence of the DNA intercalating agent YOYO-1 to characterize capsid 
disruption as a function of temperature in Ad5-wt and A5-VII- particles. In both cases, the 
fluorescence emission of YOYO-1 increased with the temperature, as the genome became 
exposed to the solvent (Fig. 2). The half-transition temperature (T0.5) estimated for Ad5-wt was 
47.35 ± 0.06 ºC, in agreement with previous studies (13, 22, 24, 38, 39). In contrast, for Ad5-VII- 
the maximum rate of DNA exposure happened at 44.45 ± 0.10 ºC. This result indicates that 
Ad5-VII- particles are thermally less stable than Ad5-wt. 
To analyze the mechanical stability of the Ad5-VII- particles, we used mechanical fatigue 
induced by atomic force microscopy (AFM). This method involves repeated imaging of the same 
virus particle using very low forces (~100 pN), far below the breaking force of the capsid. In this 
way, we simultaneously induce and monitor the gradual disassembly of single virus particles 
(23). Topography images taken at the beginning of the experiment showed no differences 
between Ad5-wt and Ad5-VII- particles (Fig. 3a, panels #1). As the experiment proceeded, 
mechanical fatigue caused the sequential removal of pentons, followed by complete particle 
collapse. In the example shown in Fig. 3a, we show that for Ad5-VII- the first penton fell off the 
capsid at image #3, and the third penton at image #9. The capsid collapsed after #18 images. In 
contrast, in the Ad5-wt the first penton falls off at image #43, and the capsid collapsed at image 
#59. 
We quantified the rate of penton loss for 9 Ad5-VII- and 7 Ad5-wt viral particles. In Fig. 3b, 
pentons are considered independent identities, and the normalized penton population for all 
studied particles is plotted along the number of images taken. At the beginning of the 
experiment, all observable pentons are present for the 16 studied particles (penton population = 
1). As the experiment proceeds, pentons fall off and the penton population decreases until there 
are no more observable pentons. The penton release distribution follows an exponential decay 
for both types of particles. The mean life-time of a penton is 12 images for Ad5-VII-, and 26 
images for Ad5-wt, indicating that penton loss occurs faster in Ad5-VII- particles (Table 1). This 
higher propensity to release pentons agrees with our observations showing that lack of core 
protein VII increases the particle internal pressure(33).  
To further analyze the disassembly dynamics, we quantified the variation in particle volume 
during the mechanical fatigue assays (Fig. 3c). At the beginning of the experiment, the particle 
volume remained constant for all particles analyzed. After losing the three pentons on the upper 
facet, the volume drops at a similar rate for both kinds of particles (13% volume loss/image for 
Ad5-VII-, 14% volume loss/image for Ad5-wt). A clear difference, however, was the time 
elapsed until the particle volume starts to decrease: Ad5-wt particles lost 50% of their volume 
after being imaged ~50 times, while for Ad5-VII- the same decrease in volume occurred after 
only 15 images (Fig. 3d). That is, Ad5-VII- particles start losing volume earlier than Ad5-wt 
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particles, consistent with the penton release tendency. Therefore, penton resilience determines 
the stability of the virus particle under mechanical fatigue. 
In conclusion, our results so far indicate that Ad5-VII- particles are less stable than Ad5-wt 
under both thermal and mechanical stress. Therefore, the defect of Ad5-VII- virions in protein VI 
exposure is unlikely due to higher mechanical or thermal stability, although it might be due to an 
inability of the VII- virions to respond to the pulling forces from CAR receptor movements and 
holding forces of the immobile integrins. 
 
Lack of density in the Ad5-VII- cryo-EM map hexon cavity confirms the interaction of core 
protein VII with hexon 
In Figs. 2 and 3 we have shown that Ad5-VII- particles are damaged at lower stress levels than 
Ad5-wt upon heating (Fig. 2, accessibility of YOYO-1 to the genome) or repeated 
nanoindentation (Fig. 3, penton and particle volume loss). Also in agreement with their 
decreased stability, we show that before entering the cell, many Ad5-VII- particles were already 
damaged to such an extent as to allow antibody binding to protein VI (Fig. 1b, time point 0). 
Label for protein VI at this point could originate from molecules still attached to capsid 
fragments, or just in the near proximity. However, there is no increase in the label for protein VI 
in the first 30 min post-entry, a behavior very different from that of Ad5-wt (Fig. 1b). All these 
results combined indicate that, even if Ad5-VII- particles are more prone than Ad5-wt to lose 
their structural integrity, in the cell they are unable to release enough copies of the lytic peptide 
to cause endosome escape. To try to understand why, we investigated the structural differences 
between Ad5-VII- and Ad5-wt particles using cryo-electron microscopy (cryo-EM) (see SI 
Appendix, Fig. S4). A difference map was calculated by subtracting the Ad5-VII- map from Ad5-
wt, to show density corresponding to elements present in the mature virion but absent when the 
major core protein is missing. This map (Fig. 4a, red density) showed small differences located 
in the interior of the capsid, near the rim of the hexon cavity (red circles, Fig. 4a). When we 
overlap the most recent Ad5-wt structure (PDB-6B1T (2)) with our maps, we observe that one of 
the small densities absent in Ad5-VII- perfectly matches the position of peptide VIIN2 traced by 
Dai et al. inside the cavity of hexon 2 in the Asymmetric Unit (AU) (Fig. 4b and 4c). 
When the difference map is contoured at 1.5σ, we observe five red densities in the AU, one 
inside each of hexon trimers 1, 2 and 3, and two inside hexon 4. These difference densities 
occupy positions near the VIN/VIIN2 binding pocket in hexon, according to (2). Since there are 
~360 copies of pVI (3, 4) and 720 hexon monomers (organized in 240 trimers) in the capsid, at 
least half the possible binding pockets (six out of twelve per AU) would be available for pVII to 
bind, in good agreement with the observation of 5 empty pockets when VII is not present (Fig. 
4a). However, all difference densities are weaker than the density corresponding to hexon (3σ), 
indicating disorder or partial occupancy. At lower contour level (1σ), 8 red densities located near 
the VIN/VIIN2 binding pocket in hexon can be observed in the difference map AU (see SI 
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Appendix, Fig. S5). One of these, located in the peripentonal hexon (hexon 1) cavity, covers the 
space occupied by one of the pVIN peptides traced in the Ad5-wt structure. One more difference 
blob per AU appears at nearly noise level (0.8σ, see SI Appendix, Fig. S5).  
Given that protein VII is the only component missing from the Ad5-VII- particle (29), we interpret 
the (Ad5-wt minus Ad5-VII-) difference densities as an indication of binding sites left empty by 
the absence of the major core protein. This result supports the location of part of protein VII (the 
pVIIN2 peptide) proposed by the latest cryo-EM study on Ad5-wt (2). The fact that more 
difference blobs appear in equivalent capsid positions at lower contour thresholds is consistent 
with variable occupancy of the pVIN/pVIIN2 binding pockets across the different hexon 
monomers icosahedrally averaged in the cryo-EM map. This result indicates that in the 
complete virion, the pVIIN2 peptide has the potential to bind all hexon monomers in the capsid, 
but succeeds only in part of them, while in the rest the binding pocket is occupied by pVIN. That 
is, our observations are consistent with the hypothesis that during Ad5 assembly, pVI and pVII 
compete for the same binding site in the hexon trimer cavity. 
 
Observation of partially processed protein VI in the Ad5-VII- particle 
The inverse difference map showed the density corresponding to icosahedrally ordered 
elements present in Ad5-VII- but absent in Ad5-wt. Direct observation of the cryo-EM maps 
already revealed a clear density filling the inner cavity of hexons in Ad5-VII- but absent in Ad5-
wt (see SI Appendix, Fig. S4, white circle). This extra density is present in all hexons in the AU 
(Fig. 5 and see SI Appendix, Fig. S6), and is consistent with an increase in order for 
unprocessed polypeptide VI, as shown previously for the immature particle (Ad2 ts1) (24, 40). 
Even when contoured at low density (0.8σ, Fig. 5), the negative difference does not cover the 
pVI fragments traced in the latest Ad5-wt model (neither pVIN nor the central VI fragment), 
indicating that these regions are mostly organized in the same way in both Ad5-wt and Ad5-VII-. 
When, instead of calculating the difference map between the two cryo-EM maps, we subtract 
only the hexon density (generated from the high resolution structure) from the Ad5-VII- map, the 
conformation of the extra density inside the hexon cavity can be analyzed in more detail. In 
hexon 2, this density forms two well defined, L-shaped tubular regions directly connected to the 
C-terminal residue of the pVIN peptides traced by (2) (Fig. 6a). Secondary structure predictions 
and circular dichroism analyses indicate that the N-terminal region of protein VI after cleavage 
by AVP is predominantly α-helical (see SI Appendix, Fig. S7) (14). One of these helices would 
harbor the amphipathic, lytic peptide (Ala34-Tyr54) (13). Indeed, two α-helices, 11 and 18 
residues long respectively, can be modeled in each of the two L-shaped densities inside the 
hexon cavity (Fig. 6b). Together with the continuity with the pVIN peptides traced in the high-
resolution structure, the shape and size of the difference density indicate that each one of the 
two L-shaped tubes corresponds to ~30 residues of protein VI, still uncleaved from the pVIN 
peptide. From the last residue in these helices (~residue 65), a ~50 residue-long disordered 
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region would connect with the central fragment of the protein traced in (2), which starts at 
residue 109 (Fig 6c). Although at a limited resolution which precludes identification of side 
chains, this is the first observation of the adenovirus lytic peptide organization within the capsid. 
At the same contouring threshold, we also observed two L-shaped tubular densities inside the 
hexon 3 cavity, while in hexons 1 and 4 the density for the second tube was weaker (see SI 
Appendix, Fig. S8). These results contribute to explain the long standing puzzle of the 
stoichiometry of polypeptide VI. Given the available space, it seems very difficult to fit one copy 
of VI per hexon monomer inside the trimer cavity. Hexons 2 and 3 seem to have a preference 
for accomodating two copies of VI, while in hexons 1 and 4, although two copies can be held 
inside the cavity, there is a greater probability of finding only one. The sum of 2+2+1+1 copies 
of VI will result in the previously estimated number of 6 copies per AU. Interestingly, hexons 1 
and 4 differ from hexons 2 and 3 in their interactions with another minor coat protein, 
polypeptide VIII (1), suggesting that the presence of this minor coat protein plays a role in 
determining the hexon:VI stoichiometry. Our interpretation of the densities in the hexon cavity is 
also consistent with the observation of dimeric species when a cysteine was introduced at 
position 48 in pVI (G48C, (41). In our model, the region where residue 48 would be located 
corresponds to the elbow of the L-shaped density tubes, placing the two cysteines (one from 
each pVI molecule) close enough for a disulfide bond to form (Fig. 6d). Dimers of protein VI 
were also detected by crosslinking assays on disrupted virions and extracted cores (42) 
It has previously been shown that immature pVI has lytic activity, but binding to hexon shields 
this activity (36). The mature form of VI binds to the hexon cavity more weakly than the 
intermediate one (iVI), as indicated by assays where heating of Ad5 particles carrying the pVI 
G33A mutation caused release of mature protein VI, but not of iVI (36). Our difference mapping 
is in agreement with these observations: when core protein VII is not present and the N-terminal 
cleavage of VI does not occur, the lytic peptide remains shielded by hexon, even if capsid 
disassembly proceeded unimpeded. Alternatively, it is possible that the capsid of Ad5-VII- 
particles does not disassemble in cells, which would be supported by the observation that the 
incoming viral DNA in Ad5-VII- particles is less accessible to click chemistry labeling than the 





When Ad5 protein VII is not present during assembly, pVIN is not cleaved, and the viral particle 
remains trapped in the endosome (29). The endosome escape defect is unlikely due to the 
inability of pVIN to lyse membranes, as shown by in vitro experiments with recombinant pVI (13). 
Rather, what happens is that in Ad5-VII- particles, protein VI is not released in the endosome 
(Fig. 1), preventing the interaction between its amphipathic helix and the endosome membrane. 
The inability to release protein VI is not due to increased physical stability of the Ad5-VII- 
particles (Fig. 2 and 3). Rather, the lytic peptide remains fused to the pVIN peptide, and is 
hidden within the hexon cavity, unavailable to interact with the endosome membrane (Fig. 6). 
One intriguing question is prominent in the analysis of the Ad5-VII- particles: why is pVIN not 
cleaved when protein VII is absent? Indeed, it is not clear yet how pVIN is cleaved during 
assembly in Ad5-wt, because the highest resolution structure reported so far indicates that the 
pVIN peptide is oriented with its cleavage site hidden inside the hexon cavity, away from the 
reach of the DNA-bound AVP (see SI Appendix, Fig. S1) (2). Our observations provide new 
clues to answer these questions, prompting a new model for the role of protein VII in regulating 
capsid maturation. 
Dai et al interpreted part of the density inside the cavity of one of the hexons in the AU as a 
peptide cleaved not from pVI, but from pVII, suggesting that the two proteins could compete for 
the same binding site in hexon during assembly (2). Our cryo-EM difference maps indicate that 
pVIIN2 has the ability to bind to the same pocket as pVIN in all 12 hexon monomers in the AU. In 
one viral particle, there are 500-800 copies of pVII, and 360 copies of pVI (3, 4). That is, there 
are 860-1160 candidates to bind to 720 sites in the hexon trimer cavities. We propose that, due 
to this excess, proteins VI and VII establish a dynamic competition for hexon binding sites 
during assembly. As a result of this competition, pVI or pVII molecules carrying their hexon-
binding N-terminal peptides would continually be pushed out from the hexon cavity by their 
competitors, putting them in the path of AVP sliding on the DNA (Fig. 7). In the absence of 
protein VII, the competition does not exist: there are enough sites to bind for all pVI copies, and 
nothing to push the lytic peptide out from the hexon cavity. Thereby, the pVIN cleavage site 
would be hidden away from the protease. Consequently, (a) pVIN is not cleaved, and (b) the lytic 
peptide remains shielded by hexon, preventing virion escape from the endosome. 
The competition model we propose here may help explain previous observations on the effect 
of pVI mutations in adenovirus maturation and infectivity. In mutant G33A, pVIN is not properly 
cleaved either, but the virion retains a considerable infectious potential (25%) (36). This 
infectivity can be caused by the presence of 50% properly cleaved VI copies, but our 
competition model highlights another difference between G33A and Ad5-VII- particles. In G33A, 
although pVIN is partially uncleaved, the competition with protein VII is present, which could 
cause the lytic region to be bumped out of the hexon cavity and available for endosome 
membrane disruption. It has also been observed that in pVI-S28C mutant capsids, pVI was 
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correctly processed at both ends, but a considerable proportion of protein VII remained 
uncleaved (37). It is possible that the change in a region close to Ser31 in pVI (the residue filling 
the common pVI/pVII binding pocket in hexon) decreases its affinity for hexon sites in such a 
way that binding of the more abundant pVII would predominate, with its subsequent protection 
from the protease. The presence of uncleaved pVII bound to the hexon cavities would result in 
enhanced bridging between shell and genome, possibly causing the observed stiffening of the 
S28C particles. In agreement with the correct maturation of pVI, in this mutant infectivity was 
slightly (2-fold) higher than in the parental virus, indicating that exposure of protein VI during 
entry was unaltered, or even slightly enhanced. 
In the immature particles produced by Ad2 ts1, both pVII and pVI are present in their 
appropriate copy numbers. Therefore, it would be expected that part of the pVI molecules are 
forced out from the hexon cavity by competition with pVII. Although they would be uncleaved 
due to the mutation in AVP, in principle these molecules could be exposed and disrupt the 
endosome membrane. However, the defect in VI exposure in Ad2 ts1 seems to be related to the 
lower internal pressure exerted by the genome when condensed by the precursor versions of 





Materials and Methods 
Virus specimens 
The Ad5-wt virus used in cryo-EM, AFM and extrinsic fluorescence assays was the E1-E3 
deleted, GFP expressing Ad5/attP vector which is structurally wildtype (44). The parent virus 
Ad5-VII- contains loxP sites flanking the protein VII open reading frame and was generated and 
propagated as described (29). Ad5-VII- particles used in entry assays were produced using 
A549 cells expressing a Cre recombinase, isolated and labeled with atto 565 as previously 
described (8, 19, 45). More information can be found in Supplemental Information (see SI 
Appendix). 
 
Endocytosis and protein VI exposure assays 
Ad5-wt and Ad5-VII- particles labeled with atto 565 were added to cells at 4 °C for 60 min. 
Unbound virus particles were removed, cells were washed once with cold medium and 
incubated in a 37 °C water bath for 0, 10 or 20 min. Afterwards, intact cells were incubated with 
mouse 9C12 anti-hexon antibody at 4 ºC to tag particles at the plasma membrane. Cells were 
then fixed with 3% paraformaldehyde in PBS and stained with affinity-purified rabbit anti-VI 
antibodies (16), Alexa Fluor 680-conjugated anti-mouse and Alexa Fluor 488-conjugated anti-
rabbit antibodies (Thermo Fisher Scientific) and DAPI as previously described (21). Imaging 
was performed with a Leica SP5 confocal microscope as previously described (21). More 
information can be found in SI Appendix. 
 
Thermal stability assays 
Fluorescence emission spectra from virus samples mixed with YOYO-1 were obtained every 2 
ºC along a temperature range from 20 to 70 ºC in a Horiba FluoroLog spectrophotometer. The 
dye was excited at 490 nm and maximal emission intensity was achieved at 509 nm. More 
information can be found in SI Appendix. 
 
Mechanical stability assays 
For AFM imaging, virus samples were diluted in a solution of NiCl2 in HBS to obtain a final 
solution of 5 mM of NiCl2 and virus concentrations of 1.5–2x1011 viral particles per ml. A drop of 
20 µL of virus solution was deposited on freshly cleaved mica and incubated for 30 min at 4ºC 
before washing with 5 mM NiCl2 in HBS. The AFM (Nanotec Electrónica S.L., Madrid, Spain) 
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was operated in jumping mode in liquid with the modifications described in (46), using 
RC800PSA (Olympus, Tokyo, Japan) cantilevers with nominal spring constants of 0.05 N/m. 
Monitoring virus disassembly in real time was accomplished by repeatedly imaging each particle 
as described (23). More information can be found in SI Appendix. 
 
Cryo-EM analyses 
Methods to obtain the maps used in this work have been described elsewhere (33). To analyze 
capsid differences between Ad5-wt and Ad5-VII- particles, difference maps were calculated 
after filtering both maps at the same resolution (5.5 Å) using Xmipp and normalizing with UCSF 
Chimera. To delineate the extra density within the hexon cavities in Ad5-VII-, density maps at 
5.5 Å resolution for each hexon trimer in the AU were created from the high resolution model 




The cryo-EM maps have been deposited at the Electron Microscopy Databank with ID EM-4448 
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Figure 1. Reduced protein VI exposure in Ad5-VII- particles during entry in comparison to 
Ad5-wt. Atto 565-labeled virus particles were added to A549 cells at 4 °C for 60 min. Unbound 
particles were washed away, and cells were shifted to 37 °C for the indicated times. Intact cells 
were then incubated with mouse 9C12 anti-hexon antibody at 4 ºC to tag plasma membrane-
associated viruses, and after fixation, cells were permeabilized and stained with rabbit anti-
protein VI antibody. These primary antibodies were detected with Alexa Fluor 680- conjugated 
anti-mouse and Alexa Fluor 488-conjugated anti-rabbit antibodies. Nuclei were stained with 
DAPI, and samples were imaged by confocal microscopy. (a) Representative images shown for 
Ad5-wt (top rows) and Ad5-VII- (bottom rows) at the 0 min and 10 min time points are maximum 
projections of confocal stacks. Scale bars = 10 µm. (b) The scatter plots show per cell mean 
protein VI signal on endocytosed particles (i.e., particles devoid of 9C12 antibody signal) for 10 
min and 20 min time points, but the 0 min time point includes all cell-associated particles. One 
dot represents one cell and the number of cells analyzed is indicated. Error bars represent the 
means ± SD.  
 
Figure 2. Thermal stability of adenovirus particles with or without protein VII. Extrinsic 
fluorescence measurements showing DNA exposure to solvent upon temperature increase for 
Ad5-VII- (blue) and Ad5-wt (red). Average values and error bars corresponding to the standard 
deviation of four experiments are plotted. Dotted lines correspond to the fit according to a 
Boltzmann sigmoid function. 
 
Figure 3. Mechanical stability of adenovirus particles with or without protein VII. (a) 
Representative AFM images along fatigue experiments for Ad5–VII- and Ad5-wt particles 
adsorbed on mica. Release of the first, second and third pentons from the top facet are 
indicated with white circles. (b) Analysis of penton release for 9 Ad5-VII- and 7 Ad5-wt viral 
particles. At the beginning of the experiment, all visible pentons in the images are occupied 
(penton population = 1). The penton population decreases along the experiment. (c) 
Comparison of the evolution of Ad5-VII- and Ad5-wt particle volume during the fatigue 
experiment. (d) The image number at which each particle has undergone a 50% volume 
decrease is plotted for all particles analyzed. 
 
Figure 4. Cryo-EM difference map showing density present in Ad5-wt but absent in Ad5-
VII- particles. (a) The four hexon trimers in the AU (see inset) as seen from inside the viral 
particle are shown as a gray surface generated from the high resolution HAdV-C5 structure 
(PDB 6B1T). The difference map obtained by subtracting the two cryo-EM maps (Ad5-wt minus 
Ad5-VII-) is shown as a semitransparent red surface contoured at 1.5σ level. Cyan, green and 
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yellow ribbons correspond to the pVI and pVII fragments traced in (2), as indicated in the 
schematics in (c). The solid line red circle indicates the location of the pVIIN2 peptide (yellow 
ribbon, covered by the semitransparent difference map) traced by Dai et al. The dashed red 
circles indicate the position of four additional difference densities located at positions in the 
hexon cavity where either pVIN or pVIIN2 would bind, according to Dai et al. To remove visual 
clutter, only the 150 largest difference patches within a radius of 15 Å around the four hexon 
trimers are shown (UCSF Chimera sop zone # selected 15 maxComponents 150). The inset 
shows a schematic of the icosahedral asymmetric unit as seen from inside the particle, with the 
four hexon trimers numbered 1-4, and the positions of the 2, 3 and 5-fold icosahedral symmetry 
axes depicted by a red oval, triangle and pentagon, respectively. (b) Cutout view of hexon 2 
showing that the difference density clearly fits with the position of pVIIN2 modeled by Dai et al. 
(c) Schematic representation of proteins pVI and pVII. Numbers at the right hand side indicate 
the length of each protein (in amino acids). Arrows point to the AVP cleavage sites. Colored 
boxes represent the fragments solved by Dai et al. 
 
Figure 5. Cryo-EM difference map showing density present in Ad5-VII- but absent in Ad5-
wt particles. (a) The four hexon trimers in the AU (see inset) as seen from inside the viral 
particle are shown as a gray surface generated from the HAdV-C5 high resolution structure 
(PDB 6B1T). The difference map obtained by subtracting the two cryo-EM maps (Ad5-VII- 
minus Ad5-wt) is shown as a blue surface and contoured at 0.8σ level. Cyan, green and yellow 
ribbons correspond to the pVI and pVII fragments traced by (2), as in Fig. 4. To remove visual 
clutter, only the 80 largest difference patches within a radius of 15 Å around the four hexon 
trimers  are shown (UCSF Chimera sop zone # selected 15 maxComponents 80). (b) Zoom in 
on a cutout view of the hexon 2 trimer showing that even at this low contouring threshold the 
difference density does not cover the pVI and pVII fragments modeled by Dai et al. 
 
Figure 6. Ordered density inside the hexon cavity in Ad5-VII-. (a) A difference map obtained 
by subtracting the hexon 2 density (calculated at 5.5 Å resolution from PDB 6B1T) from the 
Ad5-VII- cryo-EM map, and contoured at 1.7σ, is shown as a gray mesh. Hexon 2 (pink) and 
two copies of the pVIN peptide (cyan) as traced in PDB 6B1T are represented as ribbons. The 
zoom at the right hand side shows the continuity between the difference density and the pVIN 
peptides traced by Dai et al. (red arrows) (b) As in (a), with two α-helices (11 and 18 residue 
long, respectively) modeled in each L-shaped tubular density inside the hexon cavity (purple). 
For a cleaner view, only a region of the difference map contained within 12 Å from the modeled 
helices is shown. (c) Model for the organization of one pVI monomer in the virion. The pVIN 
peptide traced by Dai et al. (cyan) is followed by the two α-helices modeled in the Ad5-VII- map 
(purple). A dotted line indicates the connection between helices, and the dashed line indicates a 
disordered region connecting the end of the modeled helices to the central region of pVI as 
23 
 
traced by Dai et al. The length of each helix and of the disordered segment is indicated (in 
amino acids). Residue numbers in black correspond to the limits of the pVI regions traced by 
Dai et al. (d) Model for the pVI dimer showing how our model places residue 48 of the two 
monomers in the hexon cavity in close proximity. (e) Schematic representation of polypeptide 
pVI as in Fig. 4c, with the position of the pVI lytic peptide indicated as a purple box. 
 
Figure 7: Model for dynamic competition between polypeptides VI and VII. During Ad5-wt 
assembly, the N-terminal regions of pVI and pVII (keys) compete for the same binding pocket in 
the hexon monomer (lock). This competition forces one of the two binding candidates out of the 
hexon cavity, making its N-terminal cleavage site accessible to AVP (scissors), and in the case 
of protein VI, for exposure and membrane disruption in the endosome. In Ad5-VII-, pVI has no 
competitors, and therefore its N-terminal region remains bound to and hidden inside the hexon 




Table 1. Exponential decay distribution of penton release. The penton distribution data 
follow an exponential decay function N(t)=N0e
-t, where t is the number of images taken, and 
parameters such as the penton release rate constant () and mean life-time of a penton (1/) 
can be determined. The mean penton lifetime is given as number of images; the penton release 
rate constant represents the probability to release one penton in one image. 
 
Specimen Penton release 
constant  (images-1) 
Mean penton lifetime 
1/ (images) 
N 
Ad5-VII- 0.08 12 9 
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Supplementary Methods  
Virus purification 
The Ad5-wt virus used in cryo-EM, AFM and extrinsic fluorescence assays was the E1-E3 
deleted, GFP expressing Ad5/attP vector which is structurally wildtype (1), propagated at 37ºC 
in HEK293 cells and harvested at 36 h post-infection. The parent virus Ad5-VII-loxP with loxP 
sites flanking the protein VII open reading frame was generated and propagated as described 
(2). Ad5-VII- particles were produced using the Cre66 cell line, a Cre recombinase expressing 
cell line derived from HEK-293 cells (a gift from Dr. Stefan Kochaneck, University Ulm, 
Germany), maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% 
HyClone Fetalclone III serum, penicillin, streptomycin, and 0.25 mg/ml of Geneticin (Life 
Technologies). Cre66 cells (6 x 108 total cells) were infected with 200 CsCl-purified Ad5-VII-loxP 
virus particles/cell for 1 h at 37 ºC. Infected cells were harvested 3 days after infection when full 
cytopathic effect was evident. The cells were pelleted by centrifugation, medium removed, and 
cell pellets flash frozen in liquid nitrogen for storage. Infected cell pellets were resuspended in 
DMEM and lysed by three or four freeze-thaw cycles. Cell lysates were clarified to remove 
cellular debris by centrifugation at 4000 rpm and 4 °C for 30 min. The pellet containing cell 
debris was discarded. For both Ad5-wt and Ad5-VII-, particles were purified by centrifugation at 
18 °C and 217,485g in a 1.25-1.40 g/ml CsCl step gradient (90 min), followed by a 1.31 g/ml 
isopycnic one (18 h). CsCl solutions were prepared in TD1X buffer (137 mM NaCl, 5.1 mM KCl, 
0.7 mM Na2HPO4.7H2O, 25 mM Tris-HCl, pH 7.4). Bands extracted from the gradients were 
desalted on a Bio-Rad 10 DC column, and stored in HBS buffer (20 mM HEPES pH 7.8, 150 
mM NaCl) supplemented with 10% glycerol at -80 °C until further use. 
Capsid protein concentration was quantified using the hexon fluorescence emission spectra 
obtained in a Hitachi Model F-2500 FL spectrophotometer. Sample volumes of 0.150 ml were 
examined in sealed quartz cuvettes. The sample was excited at 285 nm, and the emission was 
monitored from 310 to 375 nm using excitation and emission slit widths of 10 nm. The spectra 
were corrected by subtraction of the buffer spectrum. The maximum emission intensity for each 
spectrum was found at 333 nm and recorded. The concentration was determined from a 
calibration curve obtained with a sample of known concentration (3). 
Ad5-VII- particles used in entry assays were produced using A549 cells expressing a Cre 
recombinase (2) isolated and labeled with atto 565 as previously described (4-6), except that 
unincorporated atto 565 dye was removed with Zeba spin desalting columns (40K MWCO, 
ThermoFisher Scientific). The virus was stored in a buffer containing 10 mM Tris-HCl pH 8.1, 





Endocytosis and protein VI exposure assays 
A549 cells were seeded on coverslips at 40000 cells per well in a 24-well plate two days before 
the experiment. Ad5-wt and Ad5-VII- particles labeled with atto 565 were added to cells (MOI 
Ad5-wt ~ 62000 virus particles and Ad5-VII- ~ 149000 virus particles per cell) at 4 °C for 60 min 
in RPMI 1640 medium (without NaHCO3) supplemented with 0.2% bovine serum albumin, 20 
mM HEPES, and penicillin-streptomycin (RPMI-BSA medium). Unbound virus particles were 
removed, cells were washed once with cold RPMI-BSA medium and incubated in a 37 °C water 
bath in warm RPMI-BSA medium for 0, 10 or 20 min. Afterwards, intact cells were incubated 
with mouse 9C12 anti-hexon antibody in the RPMI-BSA medium at 4 °C for 1h to tag particles at 
the plasma membrane (the 9C12 antibody, developed by Laurence Fayadat and Wieber Olijve, 
was obtained from Developmental Studies Hybridoma Bank developed under the auspices of 
the National Institute of Child Health and Human Development). Cells were then fixed with 3% 
paraformaldehyde in PBS and stained with affinity-purified rabbit anti-VI antibodies (7) and 
Alexa Fluor 680-conjugated anti-mouse and Alexa Fluor 488-conjugated anti-rabbit antibodies 
(Thermo Fisher Scientific) and DAPI as previously described (8). Imaging was performed with a 
Leica SP5 confocal microscope as previously described.(8) Maximum projections of confocal 
stacks were analyzed by a custom-programmed MATLAB (The Mathworks) routine to score the 
number of plasma membrane-associated virus particles (particles with both the atto 565 and 
Alexa Fluor 680 signals) and internalized particles (particles with only the atto 565 signal) per 
cell, as well as protein VI signal on internalized virus particles (the MATLAB routine will be made 
available upon request). The threshold value for antibody-positive particles was determined by 
combining a virus image with an antibody image obtained from noninfected cells and taking the 
highest virus-associated antibody signal as a cutoff value. GraphPad Prism (GraphPad 
Software, Inc. La Jolla) was used for creating the scatter plots. Representative images shown in 
figures are maximum projections of confocal stacks, and the images were processed with Fiji 
applying the same changes in brightness and contrast to all image groups in the series.  
 
Thermal stability assays 
Virus samples (5x109 virus particles in a final volume of 800 µl of buffer) were incubated 
overnight at 4 °C in 8 mM Na2HPO4, 2 mM KH2PO4, 150 mM NaCl, and 0.1 mM EDTA, pH 7.4. 
A volume of 8.8 µl of YOYO-1 diluted 1:100 dilution in milliQ water from initial stock (Thermo 
Fisher Scientific, stock composition: 1 mM YOYO-1 in DMSO) was added to the virus sample 
and equilibrated for 5 min at 20 ºC before data acquisition. Fluorescence emission spectra were 
obtained employing a Horiba FluoroLog spectrophotometer equipped with a Peltier temperature 
control device. The dye was excited at 490 nm wavelength, and fluorescence emission was 
monitored from 500 to 580 nm using an excitation slit of 2 nm and an emission slit of 5 nm. 
Maximal emission intensity occurred at 509 nm. The temperature in the sample cell was 
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increased from 20 to 70 ºC, with readings every 2 ºC after holding for 0.5 min for equilibration. 
Each run took approximately one hour and a half to be completed. Raw spectra were corrected 
by subtraction of the YOYO-1 spectrum in buffer at each tested temperature. The fractional 
change in fluorescence 	 , was calculated according to equation (1): 		 	 	 	          (1) 
Where T indicates the independent variable temperature (ºC) and Fexp refers to the raw 
fluorescence signal (c.p.s) at each temperature. Fi and Ff represent the linear extrapolates, at 
this temperature, of pre-transition and post-transition base lines, respectively. A total of four 
independent experiments were considered for the averaged curve of each specimen.  The half 
transition temperatures (T0.5) were calculated from the fitting of the averaged fluorescence 
intensity curve as a function of temperature (T) to a Boltzmann sigmoid equation, Fs(T) (Origin 
software package) according to equation (2): 
	 	 	 0 	1	 exp 0.5                   (2) 
 
Mechanical stability assays 
For AFM imaging, virus samples were diluted in a solution of NiCl2 in HBS to obtain a final 
solution of 5 mM of NiCl2 and virus concentrations of 1.5–2x10
11 viral particles per ml. A drop of 
20 µL of virus solution was deposited on freshly cleaved mica and incubated for 30 min at 4 ºC 
before washing with 5 mM NiCl2 in HBS. The AFM tip was pre-wetted, and the mica was placed 
on a holder and immersed in 500 ml of the same buffer. The virus is therefore maintained in a 
hydrated, close to physiological state throughout the experiment. The AFM (Nanotec Electrónica 
S.L., Madrid, Spain) was operated in jumping mode in liquid with the modifications described in 
(9), using RC800PSA (Olympus, Tokyo, Japan) cantilevers with nominal spring constants of 
0.05 N/m. Cantilevers were routinely calibrated using Sader’s method (10). Images of 128x 128 
points and 300 x 300 nm2 were recorded scanning from left to right by applying forces of 100 pN 
at a temperature of 20 ºC to avoid thermal drift. Monitoring virus disassembly in real time was 
accomplished by repeatedly imaging each particle as described (11). To analyze volume 
changes, all images corresponding to the same virion were aligned and flooded using the 
WSXM software (http://www.wsxm.es/). The flooding height was determined for extracting only 
the volume contribution of the viral particle or major capsid debris, not of single capsomers 
spread on the substrate once disassembly started. Volume measurements were normalized to 
the initial value for each individual particle. The volume loss rate (given in volume percentage 
per image) was estimated from the slope of the volume loss curves after the three pentons in 





Methods to obtain the maps used in this work have been described elsewhere (12). Briefly, 
purified Ad5-wt and Ad5-VII- particles were vitrified in glow discharged Quantifoil R2/4 300 
mesh Cu/Rh grids using a Leica CPC plunger. Cryo-EM images (4395 for Ad5-wt, 1640 for Ad5-
VII-) were recorded at the CNB-CSIC cryoEM facility in a 200 kV Talos Arctica microscope (FEI) 
equipped with a Falcon II detector, with a total dose of 50 e-/Å2 distributed over 32 frames, at a 
nominal pixel size of 1.4 Å and defocus range between -0.5 and -3 µm. All image processing 
and 3D reconstruction tasks were performed within the Scipion framework (13). Frames were 
aligned using Motioncor2 and weighted according to the electron dose received before 
averaging (14). The CTF was estimated using CTFFIND4 (15). Micrographs were corrected for 
the phase oscillations of the CTF (phase-flipped). Particles (26661 for Ad5-wt, 27909 for Ad5-
VII-) were extracted into 752×752 pixel boxes, normalized and resized to a sampling rate of 2.8 
Å/px (376 px box size), using Xmipp (16). All 2D and 3D classifications and refinements were 
performed using RELION (Scheres 2012). 2D and 3D classification were used to discard low 
quality particles. Icosahedral symmetry was imposed throughout 3D classification and 
refinement. The class yielding the best resolution map (23060 particles for Ad5-wt, 21762 
particles for Ad5-VII-) was individually refined using the original 752 px boxed particles, yielding 
a final map at 5.5 Å resolution for Ad5-wt and 5.0 Å for Ad5-VII-. Resolution was estimated 
according to the gold-standard FSC = 0.143 criterion as implemented in RELION auto-refine 
and postprocess routines (17). These maps have been deposited at the Electron Microscopy 
Databank with ID EM-4448 (Ad5-wt) and EM-4424 (Ad5-VII-). High frequencies were boosted 
by using a temperature factor of -363 Å2 (Ad5-wt) or -440 Å2 (Ad5-VII-). The actual sampling for 
both maps was estimated using UCSF Chimera Fit in Map (18), by comparison with the HAdV-
C5 high resolution model (PDB ID = 6B1T) (19), yielding a value of 1.37 Å/px. 
To analyze the capsid differences between Ad5-wt and Ad5-VII- particles, difference maps were 
calculated after filtering both maps at the same resolution (5.5 Å) using Xmipp and normalizing 
with UCSF Chimera (vop scale # sd 1). To delineate the extra density within the hexon cavities 
in Ad5-VII-, density maps at 5.5 Å resolution for each hexon trimer in the AU were created from 
the high resolution model (PDB ID = 6B1T) using Chimera molmap, and subtracted from the 





Supplementary figures  
Figure S1: Cartoon illustrating the relative sizes of the adenovirus maturation protease 
(AVP) and the hexon cavity, as well as the location of the pVIN cleavage site. Hexon 2 is 
shown in pink ribbon. The pVIN peptide is colored cyan and the central fragment of pVI is in 

















Figure S2: Both Ad5-wt and Ad5-VII- particles are efficiently endocytosed. The dataset is 
the same as in Fig.1. The scatter plot shows the fraction of 9C12 antibody-negative virus 
particles per cell at the indicated time points, one dot representing one cell. Error bars represent 












Figure S3: Negative staining electron microscopy of the Ad5-VII- preparations used for 
the immunofluorescence experiments (a) or for cryo-EM, AFM and extrinsic fluorescence 
assays (b). Some disrupted particles are present in (a), consistent with the observation of 












Figure S4: Ad5-wt and Ad5-VII- cryo-EM maps. Left column: representative cryo-EM 
micrographs of Ad5-wt and Ad5-VII-. Right column: detail of the central sections of the cryo EM 
density maps of Ad5-wt and Ad5-VII-. Higher density is shown in white. A white line indicates 
the position of a 5-fold icosahedral symmetry axis in Ad5-wt. The white circle indicates extra 










Figure S5: Cryo-EM difference map showing density present in Ad5-wt but absent in Ad5-
VII- particles, contoured at several different thresholds. The four hexon trimers in the AU 
(see inset) as seen from inside the viral particle are shown as a gray surface generated from the 
high resolution structure (PDB 6B1T). In the two bottom panels, the difference map obtained by 
subtracting the two cryo-EM maps (Ad5-wt minus Ad5-VII-) is shown as a semitransparent red 
surface contoured at different thresholds, as indicated. Red dashed circles indicate difference 
densities located at positions in the hexon cavity where either pVIN or pVIIN2 would bind, 
according to Dai et al. Cyan, green and orange ribbons correspond to the pVI and pVII 
fragments traced by (19), as indicated in the schematics in Fig. 4c. The inset shows a schematic 
of the icosahedral asymmetric unit as seen from inside the particle, with the four hexon trimers 
numbered 1-4, and the positions of the 2, 3 and 5-fold icosahedral symmetry axes depicted by a 





Figure S6: Cryo-EM difference map showing density present in Ad5-VII- but absent in 
Ad5-wt particles, contoured at several different thresholds. The four hexon trimers in the 
AU (see inset) as seen from inside the viral particle are shown as a gray surface generated from 
the high resolution structure (PDB 6B1T). The difference map obtained by subtracting the two 
cryo-EM maps (Ad5-VII- minus Ad5-wt) is shown as a blue surface contoured at different 
thresholds, as indicated. Cyan, green and orange ribbons correspond to the pVI and pVII 
fragments traced by (19), as indicated in the schematics in Fig. 4c. The inset shows a schematic 
of the icosahedral asymmetric unit as seen from inside the particle, with the four hexon trimers 
numbered 1-4, and the positions of the 2, 3 and 5-fold icosahedral symmetry axes depicted by a 








Figure S7: Secondary structure prediction for pVI. The secondary structure prediction for 
pVI was obtained using Jpred (22). Only the N-terminal part of the protein (residues 1-120) is 
shown here. Red bars represent the predicted formation of α-helices. The position of the 














Figure S8: Density corresponding to partially uncleaved pVI inside the cavity of all hexon 
trimers in the asymmetric unit. The four hexon trimers in the AU (H1-H4) are represented as 
pink ribbons. In gray mesh, the difference density obtained by subtracting the density for each 
hexon trimer, calculated at 5.5 Å resolution from PDB 6B1T, from the Ad5-VII- cryo-EM map. 
The difference maps are contoured at 1.7σ. Three copies of the pVIN peptide (one in H1 and 
two in H2) as traced in PDB 6B1T are represented as cyan ribbons. Panels at the right hand 
side of each hexon show only the difference density and the pVIN ribbons, for a clearer view. 
Only the region of the difference map contained within 12 Å from helices modeled in the tubular 
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